137 related articles for article (PubMed ID: 20600505)
21. Mucosal immunity in the female genital tract: relevance to vaccination efforts against the human immunodeficiency virus.
Mestecky J; Kutteh WH; Jackson S
AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S11-20. PubMed ID: 7865284
[TBL] [Abstract][Full Text] [Related]
22. Polygene DNA vaccine induces a high level of protective effect against HIV-vaccinia virus challenge in mice.
Shinoda K; Xin KQ; Jounai N; Kojima Y; Tamura Y; Okada E; Kawamoto S; Okuda K; Klinman D; Okuda K
Vaccine; 2004 Sep; 22(27-28):3676-90. PubMed ID: 15315847
[TBL] [Abstract][Full Text] [Related]
23. AIDS/HIV. Developing an AIDS vaccine: need, uncertainty, hope.
Emini EA; Koff WC
Science; 2004 Jun; 304(5679):1913-4. PubMed ID: 15218131
[No Abstract] [Full Text] [Related]
24. An HIV-based lentiviral vector as HIV vaccine candidate: Immunogenic characterization.
Lemiale F; Asefa B; Ye D; Chen C; Korokhov N; Humeau L
Vaccine; 2010 Feb; 28(8):1952-61. PubMed ID: 20188251
[TBL] [Abstract][Full Text] [Related]
25. Induction of systemic and mucosal cross-clade neutralizing antibodies in BALB/c mice immunized with human immunodeficiency virus type 1 clade A virus-like particles administered by different routes of inoculation.
Buonaguro L; Visciano ML; Tornesello ML; Tagliamonte M; Biryahwaho B; Buonaguro FM
J Virol; 2005 Jun; 79(11):7059-67. PubMed ID: 15890945
[TBL] [Abstract][Full Text] [Related]
26. Maternal immune status influences HIV-specific immune responses in pups after DNA prime protein boost using mucosal adjuvant.
Bråve A; Johansen K; Palma P; Benthin R; Hinkula J
Vaccine; 2008 Nov; 26(47):5957-66. PubMed ID: 18801400
[TBL] [Abstract][Full Text] [Related]
27. Enhancement of epitope-specific cellular immune responses by immunization with HIV-1 peptides genetically conjugated to the B-subunit of recombinant cholera toxin.
Boberg A; Gaunitz S; Bråve A; Wahren B; Carlin N
Vaccine; 2008 Sep; 26(40):5079-82. PubMed ID: 18514370
[TBL] [Abstract][Full Text] [Related]
28. Intranasal immunization of young mice with a multigene HIV-1 vaccine in combination with the N3 adjuvant induces mucosal and systemic immune responses.
Bråve A; Hallengärd D; Schröder U; Blomberg P; Wahren B; Hinkula J
Vaccine; 2008 Sep; 26(40):5075-8. PubMed ID: 18450334
[TBL] [Abstract][Full Text] [Related]
29. Genital CD8+ T cell response to HIV-1 gag in mice immunized by mucosal routes with a recombinant simian adenovirus.
de Souza AP; Haut LH; Silva R; Ferreira SI; Zanetti CR; Ertl HC; Pinto AR
Vaccine; 2007 Jan; 25(1):109-16. PubMed ID: 16914235
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of immunogenicity and efficacy of combined DNA and adjuvanted protein vaccination in a human immunodeficiency virus type 1/murine leukemia virus pseudotype challenge model.
Rollman E; Mathy N; Bråve A; Boberg A; Kjerrström A; van Wely C; Engström G; Johansson S; Aperia K; Eriksson LE; Benthin R; Ertl P; Heeney J; Hinkula J; Voss G; Wahren B
Vaccine; 2007 Mar; 25(11):2145-54. PubMed ID: 17254672
[TBL] [Abstract][Full Text] [Related]
31. Membrane embedded HIV-1 envelope on the surface of a virus-like particle elicits broader immune responses than soluble envelopes.
McBurney SP; Young KR; Ross TM
Virology; 2007 Feb; 358(2):334-46. PubMed ID: 17011011
[TBL] [Abstract][Full Text] [Related]
32. Induction of neutralizing antibody against human immunodeficiency virus type 1 (HIV-1) by immunization with gp41 membrane-proximal external region (MPER) fused with porcine endogenous retrovirus (PERV) p15E fragment.
Luo M; Yuan F; Liu Y; Jiang S; Song X; Jiang P; Yin X; Ding M; Deng H
Vaccine; 2006 Jan; 24(4):435-42. PubMed ID: 16143433
[TBL] [Abstract][Full Text] [Related]
33. Transgene vaccination using Ulex europaeus agglutinin I (UEA-1) for targeted mucosal immunization against HIV-1 envelope.
Wang X; Kochetkova I; Haddad A; Hoyt T; Hone DM; Pascual DW
Vaccine; 2005 May; 23(29):3836-42. PubMed ID: 15893622
[TBL] [Abstract][Full Text] [Related]
34. The adjuvancy of OX40 ligand (CD252) on an HIV-1 canarypox vaccine.
Liu J; Ngai N; Stone GW; Yue FY; Ostrowski MA
Vaccine; 2009 Aug; 27(37):5077-84. PubMed ID: 19573639
[TBL] [Abstract][Full Text] [Related]
35. The mucosal immune system in the human female reproductive tract: potential insights into the heterosexual transmission of HIV.
Yeaman GR; White HD; Howell A; Prabhala R; Wira CR
AIDS Res Hum Retroviruses; 1998 Apr; 14 Suppl 1():S57-62. PubMed ID: 9581885
[TBL] [Abstract][Full Text] [Related]
36. Systemic and mucosal immune responses in mice after rectal and vaginal immunization with HIV-DNA vaccine.
Hamajima K; Hoshino Y; Xin KQ; Hayashi F; Tadokoro K; Okuda K
Clin Immunol; 2002 Jan; 102(1):12-8. PubMed ID: 11781062
[TBL] [Abstract][Full Text] [Related]
37. Mucosal immunity, HIV transmission, and AIDS.
Miller CJ; McGhee JR; Gardner MB
Lab Invest; 1993 Feb; 68(2):129-45. PubMed ID: 8441249
[No Abstract] [Full Text] [Related]
38. Sublingual immunization with nonreplicating antigens induces antibody-forming cells and cytotoxic T cells in the female genital tract mucosa and protects against genital papillomavirus infection.
Cuburu N; Kweon MN; Hervouet C; Cha HR; Pang YY; Holmgren J; Stadler K; Schiller JT; Anjuère F; Czerkinsky C
J Immunol; 2009 Dec; 183(12):7851-9. PubMed ID: 19933861
[TBL] [Abstract][Full Text] [Related]
39. [Characterization of the HIV-1 subunit vaccine containing the gp41 NHR domain of the HIV-1 CRF01_AE recombinant subtype in China].
Shao JP; Jiang SB; Liu SW
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Dec; 28(12):1250-3. PubMed ID: 23232514
[TBL] [Abstract][Full Text] [Related]
40. Targeting of HIV-p24 particle-based vaccine into differential skin layers induces distinct arms of the immune responses.
Liard C; Munier S; Arias M; Joulin-Giet A; Bonduelle O; Duffy D; Shattock RJ; Verrier B; Combadière B
Vaccine; 2011 Aug; 29(37):6379-91. PubMed ID: 21554912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]